What TuHURA Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 150,000 |
| Net activity | +0 | −150,000 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bianco James A | Chief Executive Officer | May 28 | Gift · G | −150,000 | — | — | 2,173,307 |
| Bianco James A | Chief Executive Officer | Oct 18 | Grant / award · A | +2,323,307 | — | — | 2,323,307 |
| Hoffman Robert | President, CEO, and CFO | Jun 01 | Grant / award · A | +59,800 | — | — | 68,902 |
| Brown Dennis M | Chief Scientific Officer | Jan 05 | Will/Inheritance · W | +363 | — | — | 5,302 |
| Hoffman Robert | President and CEO | Aug 01 | Grant / award · A | +400,145 | — | — | 455,145 |
| Brown Dennis M | Chief Scientific Officer | Aug 01 | Grant / award · A | +240,087 | — | — | 246,905 |
| Praill Scott | Chief Financial Officer | Aug 01 | Grant / award · A | +240,087 | — | — | 277,273 |
| Hoffman Robert | President and CEO | Feb 15 | Open-market buy · P | +55,000 | $0.47 | +$25.8K | 55,000 |
| Praill Scott | Chief Financial Officer | Dec 08 | Open-market buy · P | +28,700 | $0.68 | +$19.4K | 37,186 |
| Zarrabian Saiid | Head of Strategic Partnerships | Dec 07 | Open-market buy · P | +38,109 | $0.64 | +$24.3K | 55,500 |
| Zarrabian Saiid | Head of Strategic Partnerships | Dec 06 | Open-market buy · P | +11,891 | $0.59 | +$7.02K | 17,391 |
| Douglass Laura L. | Director | Nov 22 | Open-market buy · P | +3,000 | $0.74 | +$2.23K | 3,000 |
| Praill Scott | Chief Financial Officer | Apr 29 | Derivative Conversion · C | +938 | — | — | 8,486 |
| Praill Scott | Chief Financial Officer | Apr 29 | Other Transaction · J | +8 | — | — | 7,548 |
| Toth Robert Joseph Jr | Director | Apr 29 | Derivative Conversion · C | +325 | — | — | 1,566 |
| Toth Robert Joseph Jr | Director | Apr 29 | Other Transaction · J | +3 | — | — | 1,241 |
| Brown Dennis M | Chief Scientific Officer | Apr 29 | Derivative Conversion · C | +750 | — | — | 6,818 |
| Brown Dennis M | Chief Scientific Officer | Apr 29 | Other Transaction · J | +6 | — | — | 6,068 |
| Brown Dennis M | Chief Scientific Officer | Mar 31 | Other Transaction · J | +17 | — | — | 6,062 |
| Toth Robert Joseph Jr | Director | Mar 31 | Other Transaction · J | +8 | — | — | 1,238 |
Loading...
